rs1555732391

Variant summary

Our verdict is Uncertain significance.
+4 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 4 classification points (ACMG Germline Pathogenicity v2019). PM2PP3_Moderate

The NM_001127222.2(CACNA1A):c.5891A>G (p.Tyr1964Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

CACNA1A
NM_001127222.2 missense

Scores

9
9
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.68

Publications

0 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001127222.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 4 points.

PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD/XL) (base 0.0001, raised to 0.000117 by highest known P/LP ClinVar AF 0.000117) — PM2 moderate.
PP3Computational evidence supports damaging effect
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001127222.2. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CACNA1A NM_001127222.2
MANE Select
HGVSc / HGVSpc.5891A>Gp.Tyr1964Cys
Exon rankExon 40 of 47
missense
Prot: NP_001120694.1UniProt: O00555-8
CACNA1A NM_001127221.2
MANE Plus Clinical
HGVSc / HGVSpc.5894A>Gp.Tyr1965Cys
Exon rankExon 40 of 47
missense
Prot: NP_001120693.1UniProt: O00555-3
CACNA1A NM_023035.3
HGVSc / HGVSpc.5909A>Gp.Tyr1970Cys
Exon rankExon 41 of 48
missense
Prot: NP_075461.2UniProt: A0A087WW63

Ensembl Transcripts

CACNA1A ENST00000360228.11
TSL:1MANE Select
HGVSc / HGVSpc.5891A>Gp.Tyr1964Cys
Exon rankExon 40 of 47
missense
Prot: ENSP00000353362.5UniProt: O00555-8
CACNA1A ENST00000638009.2
TSL:1MANE Plus Clinical
HGVSc / HGVSpc.5894A>Gp.Tyr1965Cys
Exon rankExon 40 of 47
missense
Prot: ENSP00000489913.1UniProt: O00555-3
CACNA1A ENST00000638029.1
TSL:5
HGVSc / HGVSpc.5909A>Gp.Tyr1970Cys
Exon rankExon 41 of 48
missense
Prot: ENSP00000489829.1UniProt: A0A087WW63

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:31
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Inborn genetic diseases (1)
-
1
-
not provided (1)

Computational Scores

AlphaGenome AVI
Pathogenic26
AlphaMissense
Pathogenic1.0
BayesDel_addAF
Pathogenic0.28D
BayesDel_noAF
Pathogenic0.17
CADD
Pathogenic27
DANN
Uncertain1.0
DEOGEN2
Benign0.14T
Eigen
Uncertain0.64
Eigen_PC
Uncertain0.58
FATHMM_MKL
Uncertain0.94D
FuncVEP CTI
Pathogenic0.98
GPN-Star LLR
N/A-8.1
GPN-Star score
N/A8.1
LIST_S2
Uncertain0.97D
M_CAP
Pathogenic0.55D
MetaRNN
Pathogenic0.93D
MetaSVM
Uncertain0.53D
Mutation Taster
N/A29/71disease causing
MutationAssessor
Uncertain2.6M
PhyloP100
Benign2.7
popEVE
Benign-4.4
PrimateAI
Pathogenic0.89D
PROVEAN
Pathogenic-8.1D
REVEL
Pathogenic0.84
Sift
Uncertain0.016D
Sift4G
Uncertain0.035D
Varity_R
N/A0.83
VESM-3B
Benign-11
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.